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Abstract 
E2F-1 is the major cellular target of pRB and is regulated by pRB during cell proliferation. 
Interaction between pRB and E2F-1 is dependent on the phosphorylation status of pRB. 
Despite the fact that E2F-1 and pRB have antagonistic activities when they are overexpressed, 
the role of the E2F-1-pRB interaction in cell growth largely remains unknown. Ideally, it would 
be better to study the properties of a pRB mutant that fails to bind to E2F, but retains all other 
activities. To date, no pRB mutation has been characterized in sufficient detail to show that it 
specifically eliminates E2F binding but leaves other interactions intact. An alternative approach 
to this issue is to ask whether mutations that change E2F proteins binding affinity to pRB are 
sufficient to change cell growth in aspect of cell cycle and tumor formation. Therefore, we 
used the E2F-1 mutants including E2F-1/S332-7A, E2F-1/S375A, E2F-1/S403A, E2F-1/Y411A 
and E2F-1/L132Q that have different binding affinities for pRB to better understand the roles 
of the E2F-1 phosphorylation and E2F-1-pRB interaction in the cell cycle, as well as in 
transformation and gene expression. Data presented in this study suggests that in vivo 
phosphorylation at amino acids 332-337, 375 and 403 is important for the E2F-1 and pRB 
interaction in vivo. However, although E2F-1 mutants 332-7, 375 and 403 showed similar 
binding affinity to pRB, they showed different characteristics in transformation efficiency, G0 
accumulation, and target gene experiments.  
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1. Introduction 
The E2F family of transcription factors play a 
critical role in cell proliferation control [1, 2]. pRB was 
defined as the major cellular target of and revealed 
the regulation of E2F activity [3, 4]. Studies showed 
that E2F binds to the pocket domain of pRB [5]. The 
pRB-binding domain on the E2F-1 molecule is located 
at the C-terminus and is close to the transactivation 
domain. The C-terminal domain is required for effi-
cient pRB/E2F interaction and its functional conse-
quence [6]. The functional consequence of the 
pRB-E2F interaction is that E2F activity is repressed 
by pRB binding [7, 8]. pRB, therefore, exerts its 
growth suppression function mainly through its se-
questration of E2F activity. It was also shown that in 
some cases binding of pRB and other pocket proteins 
to E2F-1 does not simply inhibit E2F-1 activity. The 
resulting pRB/E2F-1 complex binds to the promoter 
and actively represses transcription by blocking the Int. J. Biol. Sci. 2010, 6 
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activity of surrounding transcription factors on the 
promoters [9]. The balance between these two activi-
ties in vivo is still in question. 
An ideal study to investigate the role of the 
E2F-1-pRB interaction in cell growth would be to 
study the properties of a pRB mutant that fails to bind 
to E2F, but retains all other activities. However, many 
of the pRB-binding proteins interact with similar re-
gions of pRB and the commonly used tumor–derived 
mutant alleles encode proteins that fail to interact 
with multiple pRB-binding proteins. To date, no pRB 
mutation has been characterized in sufficient detail to 
show that it specifically eliminates E2F binding but 
leaves other interactions intact. An alternative ap-
proach to this issue is to ask whether mutations that 
change E2F proteins binding affinity to pRB are suffi-
cient to change cell growth in aspect of cell cycle and 
tumor formation. Therefore we used the E2F-1 mu-
tants including E2F-1/S332-7A, E2F-1/S375A, 
E2F-1/S403A, E2F-1/Y411A and E2F-1/L132Q that 
have different binding affinities for pRB to better un-
derstand the roles of the E2F-1 phosphorylation and 
E2F-1-pRB interaction in the cell cycle, as well as in 
transformation and gene expression. E2F-1 mutants 
and their previously known characteristics were 
shown in Fig. 1. Studies have shown that phosphory-
lation of E2F-1 in vitro on serine residues 332 and 337 
prevented its binding to pRB, and mutation of these 
serine residues increased E2F-1 binding to pRB [10]. 
Phosphorylation of E2F-1 on serines 332 and 337 was 
shown to increase in cells in the late G1 phase of the 
cell cycle. Late G1 is when pRB becomes phosphory-
lated and subsequently releases E2F bound to it [11]. 
Therefore, phosphorylation of E2F-1 on serines 332 
and 337, as well as phosphorylation of pRB, could 
assist in dissociation of the pRB/E2F-1 complex in the 
late G1 phase. In contrast, others have shown that 
phosphorylation of E2F-1 in vitro on serine 375 pro-
motes binding of E2F-1 to pRB, and serine to alanine 
mutation of this residue decreased the E2F-1 binding 
to pRB [12]. Another mutant is E2F-1/S403A [10]. 
Peptide mapping of E2F-1/S403A did not reveal any 
changes in phosphorylation compared to the map of 
E2F-1/wt [12]. Interestingly, it has been shown in 
another study that site 403 is also phosphorylated and 
this phosphorylation increases the E2F-1 degradation 
[13]. Mutation S403A increased the stability of the 
E2F-1. The binding of the E2F-1/S403A mutant to pRB 
was found to be same as E2F-1/wt pRB binding in the 
yeast two-hybrid system [12]. An E2F-1 mutant has 
been described in which tyrosine 411 has been re-
placed with alanine. This mutation inhibited E2F-1’s 
binding to pRB in a two-hybrid yeast system and in 
vivo [14]. Although the site of mutation is within the 
transactivation domain of E2F-1, it did not change 
E2F-1’s full transcriptional potential. Another mutant 
is E2F-1/L132Q. The mutant no longer binds to DNA, 
but retains other activities such as pRB binding and 
transactivation [15]. In these experiments, however, 
effects of these mutants, in vivo binding to pRB, alte-
ration of the cell cycle phenotype and tumor forma-
tion, were not reported. 
 
Figure 1. E2F-1 mutants used in the present study. A. Schematic representation of the functional domains of E2F-1 and 
mutation sites. Each domain is represented by a shaded box and their function is described in the top part of the figure. Each 
mutation is shown by arrows at the bottom of the figure. B. Previously described effects of mutation. Int. J. Biol. Sci. 2010, 6 
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In this study, we showed that in vivo phospho-
rylation at amino acids 332-337, 375 and 403 is im-
portant for the E2F-1 and pRB interaction. However, 
although E2F-1 mutants 332-7, 375 and 403 showed 
similar binding affinity to pRB, they showed different 
characteristics in transformation efficiency, G0 accu-
mulation, and target gene experiments. More impor-
tantly, findings suggest that free E2F-1 provides the 
tumor cells with a growth advantage beyond simply 
shortening G1. 
2. Materials and Methods 
2.1. Cells and viruses  
ψ-CRE, a murine fibroblast cell line was used in 
these experiments [16]. The cells were grown in 
DMEM supplemented with 5% (vol/vol) fetal bovine 
serum and 5% calf serum in a 5% CO2 atmosphere at 
370C [17]. Retroviral vector, Linker Neo CMV E2F-1 
was used to express E2F-1/wt and E2F-1/mutant 
genes as described below. Linker Neo CMV E2F-1 is 
identical to Linker CMV T [18] except that the large T 
antigen gene from simian virus 40 was replaced by a 
cDNA, approximately 1326 bps long, encoding 
E2F-1/wt [19] and E2F-1 mutants [8, 12, 15]. Mutant 
cDNAs including E2F-1/S332-7A, E2F-1/S375A, and 
E2F-1/S403A [12] were obtained from Dr. A. Zante-
ma, mutant E2F-1/L132Q [15] was obtained from Dr. 
J. R. Nevins and E2F-1/Y411A [8] was obtained from 
Dr. K. Helin. pX17 is a retroviral vector [20], similar to 
Linker Neo CMV E2F-1, encodes the neomycin resis-
tance gene but does not encode E2F-1 gene. pX17 was 
used as negative control in the experiments. To pro-
duce infectious virus, the recombinant plasmids en-
coding Linker Neo CMV E2F-1s were transfected to-
gether with helper virus containing vector 
(SV-A-MLV-env) which encoded genes needed to 
complement the linker virus, but did not encode 
whole virus [21], into Cos-7 packaging cells using the 
calcium-phosphate transfection method [18]. Two to 
three days later, virus containing medium was col-
lected from these cells and used to infect established 
ψ-CRE murine cell lines [17]. E2F-1 wt and E2F-1 
mutants expressing cells used in the experiments 
were chosen from at least 5 different CRE cell lines for 
e a c h  o f  i n d i v i d u a l  E 2 F - 1 .  E a c h  c e l l  l i n e s  w e r e  p r e -
pared from the different retroviral infection experi-
ments and cell clones were pooled from cells growing 
in the presence of G418. All the experiments including 
cell cycle analysis, transformation and gene expres-
sion analysis were run simultaneously from the same 
group of cells. 
2.2. Immunoblotting  
To prepare cell-free extracts, an equal number of 
cells were split into dishes. Nearly confluent dishes of 
cells were washed with sterile TBS (10 mM Tris [pH 
8.0], 50 mM NaCl), and then lysed by addition of 1 ml 
of lysis buffer (50 mM Tris [pH 8.0], 5 mM EDTA, 150 
mM NaCl, 0.5% NP-40, 1 mM PMSF and 0.01 mg of 
aprotinin per ml [22] to the cell monolayer. Cells were 
scraped from the dishes into microfuge tubes and 
incubated on ice for 30 min with inversion. Lysed cells 
were centrifuged at 11,150 x g for 10 min at 40C to 
remove cell debris. The total extract volume was de-
termined, and frozen in aliquots at -700C. In addition 
to the plate of cells used to make extracts, an identical 
plate was trypsinized and the cells counted to deter-
mine cell number. In this way a volume of extract 
corresponding to a given cell number could be ana-
lyzed by SDS-PAGE. Extract prepared from 4x104 cells 
was used. From the previous studies, it is known that 
overexpression of E2F-1 decreases the cell size. 
Therefore we used the cell number to equilibrate the 
individual cell extracts on immunoblots. To this vo-
lume of extract was added one-sixth of the total vo-
lume of loading buffer (48 mM Tris [pH 6.8], 18.5% 
SDS, 3.94 M β-mercaptoethanol, 31% glycerol and 3% 
bromophenol blue) and the mixture was boiled for 3 
min. Proteins were analyzed by SDS-PAGE using 10% 
gels [23].  
Proteins were transferred from the gel to Hy-
bond ECL membranes (Amersham; Arlington 
Heights, IL) using a Hoefer (San Francisco, CA) TE 
Series Transphor Unit. Membranes were blocked at 
room temperature on a shaking platform with wash 
buffer (0.1% Tween-20 in TBS) containing 5.0% dehy-
drated low fat milk for 45 min and then for 45 min in 
wash buffer containing 1% low fat milk and 1% bo-
vine serum albumin. The membranes were rinsed in 
wash buffer and then incubated with an appropriate 
primary antibody (see below) diluted at 1:500 to 
1:2000 in wash buffer containing 5% milk for 1 to 2 
hrs. The membranes were washed four times in wash 
buffer as before and then incubated with a secondary 
antibody diluted at 1:2000 in wash buffer containing 
5.0% low fat milk for 1 h. The membranes were 
washed three times as before in wash buffer. The 
wash buffer in the last wash containing no Tween-20. 
Equal volumes of ECL detection reagents 1 and 2 
(Amersham) were mixed and added to the mem-
branes for 1 min. The membranes were then imme-
diately exposed to Hyperfilm-ECL (Amersham) [24].  Int. J. Biol. Sci. 2010, 6 
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2.3. Antibodies  
The antibody used in immunoblotting for detec-
tion of E2F-1, was rabbit anti-human E2F-1 (C-20), 
polyclonal antibody (Santa Cruz Biotechnology; Santa 
Cruz, CA). The secondary antibodies used in immu-
noblotting were horseradish peroxidase conjugated 
sheep anti-mouse (Sigma) and donkey anti-rabbit 
(Amersham), which were used for reaction with mo-
noclonal and polyclonal primary antibodies, respec-
tively. The antibodies used for immunoprecipitation 
of E2F-1 and pRb were KH95 (Santa Cruz Biotech-
nology) and G3-245 (Pharmingen; San Diego, CA) 
monoclonal antibodies, respectively. All these anti-
bodies have been shown to react with mouse proteins. 
2.4. Soft agar assays  
Five or ten thousand cells were plated in 1 ml of 
top agar composed of DMEM supplemented with 5% 
fetal bovine serum and 5% calf serum and containing 
0.38% Noble agar [24]. This suspension was seeded 
into 35-mm diameter dishes over a 2 ml layer of soli-
dified bottom agar containing DMEM and 0.5% Noble 
agar. Dishes were maintained at 37°C in a humidified 
5% CO2  atmosphere. After 3 weeks, colonies were 
either photographed or counted. For photomicro-
graphs, dishes were stained with 
p-iodonitrotetrazolium violet [25] and photographed. 
For counting, colonies were visualized with a micro-
scope using low power magnification and those 
greater than 50 µm in diameter were counted. Six mi-
croscope fields per dish were counted and used to 
calculate the total number of colonies on the entire 
dish (based on dish surface area). Colony counts were 
obtained from four dishes each cell line for per expe-
riment [26]. The data are expressed as the means of 
counts from five independent experiments.  
2.5. Cell cycle synchronization 
To synchronize cells by serum starvation, 5 x 105 
cells were seeded into 10-cm dishes. Forty-eight hrs 
later, cells were washed with PBS and DMEM sup-
plemented with 0.5% fetal bovine serum was then 
added. After 60 h, cells were stimulated into the cell 
cycle by addition of complete medium (DMEM sup-
plemented with 5% (vol/vol) fetal bovine serum and 
5% calf serum). Samples for total RNA preparation 
and flow cytometry were collected at time 0 and ap-
propriate intervals thereafter as indicated. 
2.6. Flow cytometry  
To analyze cellular DNA content, cells were 
fixed and stained [27] [24]. Briefly, 106 trypsinized 
cells were washed three times with PBS and then fixed 
by incubation with 50 μl of 0.125% paraformaldehyde 
at 370C for 5 min. Then 450 μl of ice-cold methanol 
was added to the sample. The fixed cells were washed 
three times with 0.1% Triton X-100 in PBS and treated 
with RNase A (0.04 Kunitz units) for 30 min. The cells 
were then stained with 50 μg of propidium iodide per 
ml. Cell analysis was performed using a Coulter 
EPICS Elite EPS flow cytometer (Coulter Electronics; 
Miami, FL). Excitation used the 488-nm line of an ar-
gon laser operating at 100 mW. Red fluorescence was 
collected above 570 nm. A doublet discriminator 
(peak versus integrated red signal) was used as the 
primary gate to eliminate cell aggregates. Red fluo-
rescence was displayed on a linear scale. The fraction 
of the total cell population present in each of the G1, S 
and G2/M cell cycle phases was obtained from DNA 
histograms by mathematical modeling using MPLUS 
software (Phoenix Flow Systems; San Diego, CA [18].  
2.7. Immunoprecipitation 
Immunoprecipitations were performed using 
300 µg of cell-free extract prepared as described in the 
immunoblotting procedure. The extracts were prec-
leared by incubation with Protein G Plus-/Protein 
A-Agarose beads (Oncogene Science; Uniondale, NY) 
that had been treated with BSA. The BSA-treated 
beads were prepared by incubating Protein G 
Plus-/Protein A-Agarose beads on a rotating platform 
in lysis buffer containing 1% BSA at 4°C for 2 h. The 
BSA-treated beads were then washed twice in lysis 
buffer and added to the cell-free extract. The extract 
containing the BSA-treated beads was incubated at 
4°C for 3 h on a rotating platform. Beads were then 
removed from the extracts by centrifugation at 3150 x 
g for 5 min at 4°C. E2F-1 or pRB was immunopreci-
pitated from precleared extracts by adding 2 µg of 
specific antibodies and 20 µl of BSA treated Protein G 
Plus-/Protein A-Agarose beads [24]. This mixture was 
incubated for 15 h and centrifuged as described 
above. The immune complexes were washed 4 times 
with lysis buffer and then analyzed by SDS-PAGE 
and immunoblotted as described above.  
2.8. Total RNA isolation 
RNA STAT-60 Total RNA (TEL-TEST, INC.; 
Friendswood, TX) isolation reagent kit was used and 
its protocol followed for total RNA isolation. Cells in 
culture dishes were homogenized with RNA 
STAT-60, followed by RNA extraction using chloro-
form. RNA was precipitated with 0.5 vol. of isopro-
panol followed by washing with 75% ethanol [24]. The 
quality of the samples was checked electrophoreti-
cally, and quantification was done spectrophotome-
trically. Two independent RNA preparations were 
used in the experiment. Int. J. Biol. Sci. 2010, 6 
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2.9. Primers used in the MRT-PCR 
All primers for E2F-1 target genes were designed 
with the Primer3: WWW primer tool program 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) 
and are described previously [24]. Primers were made 
by IDT, Inc. (Coralville, IA). 
2.10. Semiquantitative Multiplex RT-PCR 
Multiplex RT-PCR was performed using Pro-
mega’s Access RT-PCR system [24]. Importantly, 
RT-PCR was used first to determine the linear range 
of target genes. Second, the linear range of the internal 
standard was determined using β-actin and β-actin 
competimer (QuantumRNA β-actin internal stan-
dards, Ambion). Conditions for MRT-PCR were op-
timized after determining the β-actin and β-actin 
competimer ratio. PCR cycles were optimized so that 
the target gene would be in the linear range. Reactions 
contained AMV-RT and Tfl DNA polymerase, 
AMV/Tfl Reaction Buffer, dNTP mix, specific up-
stream and downstream primers, β-actin and β-actin 
competimer primers, MgSO4, and RNA template. The 
PCR machine was programmed as follows: 480C for 45 
min to synthesize first strand cDNA; 940C for 2 min to 
denature template; 940C 45 sec for denaturation; at 
600C for 45 sec for annealing; and 680C for 1 min for 
extension. The PCR products were run in a 1.5% aga-
rose gel and the gel was stained with EtBr. EtBr sig-
nals were analyzed by computer assisted densitome-
try. 
3. Results 
3.1. Overexpression of E2F-1/wt and 
E2F-1/mutant genes in 
ψ-CRE cell line 
We used the mouse fibroblast ψ-CRE cell line 
because it has the highest amount of pRB protein 
among the cell lines C3H10T1/2, BALB/c-3T3 and 
NIH 3T3 (data was not shown) we evaluated. We es-
tablished 7 cell lines using retroviral vectors that 
overexpress the control pX17 (the retroviral vector 
with no insert, negative control), E2F-1/wt (positive 
control), or E2F-1/mutants that have different bind-
ing affinities for pRB. E2F-1 mutants and their pre-
viously known characteristics were shown in Fig. 1. 
Since the phenotypes produced by any given 
E2F-1 are likely to depend on the amount of E2F-1 
expressed, it was necessary to compare the cells that 
expressed E2F-1 at roughly equivalent levels. There-
fore individual E2F-1 wt and each E2F-1 mutant was 
chosen from at least 5 different CRE cell lines for each 
of individual E2F-1 such that all chosen cell lines had 
approximately equivalent levels of E2F-1. Fig. 2 shows 
the chosen cell lines expressing E2F-1. These cell lines 
were called E2F-1/wt, E2F-1/S332-7A, E2F-1/S375A, 
E2F-1/S403A, E2F-1/Y411A and E2F-1/L132Q. In 
addition, pX17 viruses containing cells were used as 
control. Each cell lines were prepared from the dif-
ferent retroviral infection experiments and cell clones 
were pooled from cells growing in the presence of 
G418. All the experiments including cell cycle analy-
sis, transformation and gene expression were run si-
multaneously from the same group of cells. The cell 
lines shown in Fig. 2 were used for the remaining ex-
periments of this manuscript. 
 
 
Figure 2. Phosphorylation pat-
terns of E2F-1/wt and mutants. 
Cell free extracts from an equiv-
alent number of cells (5 X 10
4) of 
wt and E2F-1 mutants were 
analyzed by immunoblotting us-
ing anti-E2F-1 specific polyclonal 
antibody after separation on 10% 
SDS-PAGE. For loading control 
β-actin expression analyzed using 
anti-  β-actin specific polyclonal 
antibody. The position of the 
E2F-1 bands is indicated on the 
right. 
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3.2. E2F-1 overexpressing cells show different 
phenotypic characteristics 
Microscopic examination of E2F-1 overexpress-
ing cells in cell culture showed some different cha-
racteristics. Some E2F-1 overexpressing cells were 
much larger than normal and contained more than 
one nucleus. Multiple nuclei are characteristic of 
transformed cells [28, 29]. All the E2F-1 overexpress-
ing cell lines were multinucleated to varying degrees. 
However, it was most striking in cells overexpressing 
the E2F-1/S332-7A and E2F-1/Y411A mutants (Fig. 
3).  
3.3. The E2F-1/wt and E2F-1/mutants showed 
banding patterns dependent on phosphorylation 
Previously we showed that E2F-1/wt could be 
separated into a series of different bands by 
SDS-PAGE. These bands were shown to be differen-
tially phosphorylated forms of E2F-1 [30]. Similar to 
these results, this study confirmed that immunoblot 
analysis of cell extracts from the overexpressing 
E2F-1/wt cells displayed 8-10 different E2F-1 bands 
that reacted with the anti-E2F-1 specific antibody. 
E2F-1 mutants except E2F-1/L132Q used in this study 
showed different banding patterns than those of 
E2F-1/wt (Fig. 2). Some of E2F-1 mutants also showed 
8-10 bands. However, the density distribution of 
E2F-1/mutants’ bands was different than that of the 
E2F-1/wt.  
 
 
Figure 3. E2F-1 overexpressing cells showed altered characteristics in the culture. Some cells were much larger than 
normal and contained more than one nucleus. A. Control (not overexpressing E2F-1), B. Cell culture overexpressing 
E2F-1/wt. Arrows show the multinuclear cells. 
 Int. J. Biol. Sci. 2010, 6 
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3.4. Interaction between E2F-1/wt or 
E2F-1/mutants and pRB 
As mentioned previously in introduction part, 
the E2F-1 mutant pRB interactions were mostly de-
scribed in vitro and in the yeast two-hybrid system. 
Therefore it would be important to show E2F-1 mu-
tants pRB binding in cell. To test in vivo affinity of the 
E2F-1 mutant proteins for pRB, E2F-1 was immuno-
precipitated from extracts made from asynchronously 
growing E2F-1/wt or E2F-1/mutant cell lines using 
an anti-E2F-1-specific antibody. The immunoprecipi-
tated proteins were then divided into two equal ali-
quots. One aliquot of the immunoprecipitated pro-
teins was blotted onto nitrocellulose membranes fol-
lowing resolution by SDS-PAGE and then probed 
with an anti-E2F-1 specific antibody. The other aliquot 
was treated similarly and then probed with an an-
ti-pRB specific antibody. In this way, it was possible 
to determine the amount of pRB 
co-immunoprecipitated with E2F-1, relative to the 
total amount of E2F-1 present in each of the cell lines 
(Fig. 4).  
After the E2F-1/wt/pRB binding ratio was 
normalized to 1, we observed that 
E2F-1/S332-7A/pRB and E2F-1/S403A/pRB binding 
increased approximately 3-fold compared to that of 
E2F-1/wt-pRB binding (Fig. 4). E2F-1/S375A/pRB 
binding increased approximately 2.5-fold to that of 
E2F-1/wt/pRB binding. E2F-1/Y411A/pRB binding, 
on the other hand, decreased approximately 4-fold in 
comparison to E2F-1/wt/pRB binding. The 
E2F-1/L132Q/pRB binding ratio was found to be 
essentially equal to the E2F-1/wt/pRB binding ratio 
as expected. 
 
 
Figure 4. Co-immunoprecipitation of pRb and E2F-1. A. Cell free extracts from the ψ-CRE cell lines overexpressing 
E2F-1/wt, control (pX17), and E2F-1/mutants were co-precipitated with a monoclonal antibody specific for E2F-1 was 
followed by western blotting with E2F-1 polyclonal antibody or pRB polyclonal antibody as described in materials and 
methods. B. The results of immunoblots were analyzed by video-assisted densitometry. The bars show the relative den-
sitometry ratios of pRB to E2F-1 for each cell line. The pRB/E2F-1 ratio for E2F-1/wt overexpressing cells was given a value 
of 1.0. Values for other cell lines are relative to this. Values are mean ± S.E.M., n=3, * P< 0.05 compared to ψ-CRE E2F-1/wt 
cell lines.  Int. J. Biol. Sci. 2010, 6 
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3.5. Transformation of cells overexpressing 
E2F-1/wt or E2F-1/mutants 
As shown previously, overexpression of E2F-1 
increase the transformation of cell, therefore we 
aimed to see how E2F-1 mutants would change the 
transformation efficiency [26, 31]. 
Since anchorage-independent growth of fibrob-
last correlates highly with tumor formation in animals 
[32], anchorage-independent growth of E2F-1 over-
expressing cells was tested by plating the cells in soft 
agar medium and assaying the ability of the cells to 
form colonies. Fig. 5 A and B shows mi-
crograph of control (pX17) and the E2F-1 
overexpressing cells after growth in soft 
agar for three weeks. The micrographs 
show that E2F-1 overexpressing cells 
formed colonies in soft agar and were 
therefore capable of proliferating in an an-
chorage-independent manner.  
All the E2F-1 expressing cell lines 
(E2F-1/wt and E2F-1/mutants), except the 
E2F-1/S403A mutant, showed significant increases in 
transformation, compared to the control (pX17) cell 
line. The mutants E2F-1/S332-7A and E2F-1/Y411A 
showed a significant increase from the E2F-1/wt 
overexpressing cell line. The E2F-1/S375A and 
E2F-1/L132Q mutants overexpressing cell lines 
showed a significant difference in colony number 
compared to the mock control, but no difference 
compared to E2F-1/wt overexpressing cells. The 
E2F-1/S403A mutant did not significantly increase the 
transformation frequency compared to control (pX17) 
(Fig. 5). 
 
 
 
Figure 5. Representative soft agar fields de-
monstrating colony formation by transformed 
cells. Cells were plated in soft agar medium, 
stained and photographed as described in ma-
terials and methods. Colonies greater than 50 
μm in diameter were scored after three weeks 
of growth. A. micrograph of control (pX17) 
cells after growth in soft agar for three weeks. 
B. micrograph of the E2F-1 overexpressing cells 
after growth in soft agar for three weeks. C. 
Transformation frequency was expressed as the 
percentage of total plated cells that formed 
colonies. Values are mean ± S.E.M., n=5, *P< 
0.05 compared to control (pX17) ψ-CRE cell 
line, # P< 0.05 compared to ψ-CRE E2F-1/wt 
cell lines. 
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3.6. The E2F-1/wt and E2F-1/mutants change 
G0/G1 checkpoint controls. 
Overexpression of E2F-1 in cells alters cell 
growth regulation, as reported previously [2]. In this 
study, the G0/G1 phase accumulation of the different 
E2F-1 mutants was determined by using flow cyto-
metric analysis.  
All of the E2F-1 mutants, except E2F-1/L132Q, 
showed significantly less ac-
cumulation in G0, compared to the control (pX17) 
cells. Furthermore, E2F-1/Y411A and E2F-1/S403A 
showed less accumulation in G0/G1 as compared to 
E2F-1/wt expressing cells (Fig. 6). However, the other 
E2F-1 mutants were not significantly different from 
the E2F-1/wt cells. 
 
Figure 6. Cell cycle analysis of 
cell lines expressing E2F-1 mu-
tants. A. Cells were starved in 
0.5% FBS for 60 hours, at which 
time the first samples were taken 
to measure the G0 value of the 
different E2F-1 mutants and wt. 
Cells are fixed with methanol, 
treated with RNAse, stained with 
propidium iodide, and then ana-
lyzed by flow cytometry. DNA 
histograms were analyzed by the 
program Mplus. The x-axis shows 
the DNA content and the y-axis 
shows cell number. B. Number of 
E2F-1/wt or E2F-1/mutant over-
expressing cells in G0/G1 phase. 
Values are mean ± S.E.M., n=3, 
*P< 0.05 compared to control 
ψ-CRE cell line, # P< 0.05 com-
pared to ψ-CRE E2F-1/wt cell 
lines. Int. J. Biol. Sci. 2010, 6 
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Figure 7. Expression levels of the target genes in asynchronously growing ψ-CRE cells overexpressing E2F-1/wt and 
E2F-1/mutants. A. MRT-PCR of the total RNA of the ψ-CRE cells overexpressing E2F-1/wt and mutants was carried out as 
described in materials and methods and products were analyzed on a 1.5% agarose gel. The gel was stained with EtBr, and 
EtBr signals were analyzed by computer assisted densitometry. B. Results are presented as % change in expression of target 
genes for each cell line compared to control (px17), which was given the value of 100.0. Bar 1, 2, 3, 4, 5, 6, and 7 represent 
control (px17), E2F-1/wt, E2F-1/S332-7A, E2F-1/S375A, E2F-1/S403A, E2F-1/Y411A and E2F-1/L132Q, respectively. Values 
are mean ± S.E.M., n=3, *P< 0.05 compared to control ψ-CRE cell line, # P< 0.05 compared to ψ-CRE E2F-1/wt cell lines. 
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3.7. Effects of E2F-1/wt or E2F-1/mutants on 
target gene expression 
It seems likely that the different phenotypic 
changes that occur in the mutants are a result of 
changes produced by alterations in the expression of 
E2F-1 target genes. E2F-1 target genes, such as RB, 
c-myc, b-myb, DHFR, TK, cdc2, cyclin D and others, 
are important cell cycle regulators. Therefore effects of 
E2F-1 mutants on target gene expression were com-
pared to E2F-1/wt and control (pX17) using semi-
quantitative Multiplex RT-PCR.  
Results obtained from the asynchronized proli-
ferating cells showed that, overall, endogenous E2F-1 
target genes, including DHFR, b-myb, cyclin D1, cdc2, 
c-myc, TK and RB, were deregulated in E2F-1/wt and 
mutants overexpressing cells (Fig. 7). Based on the 
results obtained, although not all of them are statisti-
cally significant, the expression levels of genes in-
cluding the DHFR, b-myb, cdc2, c-myc, cyclinD1 and 
TK were showed similar result and were less re-
pressed in cell lines overexpressing E2F-1/S332-7A, 
E2F-1/S375A, E2F-1/S403A, E2F-1/Y411A and 
E2F-1/L132Q compared to the expression of the same 
genes in the cell lines overexpressing E2F-1/wt. The 
expression of cyclinD1 in all cells expressing E2F-1 
mutants are statistically less repressed compared to 
the cell expressing E2F-1/wt. In addition to cyclin D1, 
the expression of the DHFR, b-myb, c-myc in the cells 
expressing E2F-1/Y411A or E2F-1/L132Q is less re-
pressed statistically compared to E2F-1/wt and the 
expression of the cdc2 in the cells expressing 
E2F-1/L132Q is less repressed statistically compared 
to E2F-1/wt.  
Very different results were observed with RB 
expression (Fig. 7) than those described for the other 
target genes, which showed lowered expression in 
cells overexpressing E2F-1 compared to the control 
(pX17). RB expression was significantly higher in the 
E2F-1/wt and E2F-1/mutants except in the 
E2F-1/L132Q as compared to controls. Fig. 7 shows 
that RB expression increased about two-fold in the 
cells overexpressing E2F-1/S403A and E2F-1/Y411A 
compared to that of controls. They were also signifi-
cantly higher than the RB expression in cells overex-
pressing E2F-1/wt. The most interesting results were 
obtained with the E2F-1/L132Q, which is the only 
mutant in which RB expression is lower than that of 
the control. 
4. Discussion 
The structural consequences of E2F-1 phospho-
rylation are currently unknown. However from this 
data it is suggested that phosphorylation induces 
conformational changes resulting in the promotion of 
E2F-1-pRB interaction. Ser-332-337, ser-375 and 
ser-403 are not in the minimal domain of E2F-1 that is 
necessary and sufficient to interact with pRB. This 
makes it unlikely that phosphorylation is merely act-
ing to sterically change the interaction with pRB. 
Thus, the regulatory effects of phosphorylation of 
these residues must act at a distance. Together these 
facts suggest that changes in phosphorylation affect 
the affinity of E2F-1 for pRB via conformational 
changes.  
The interaction between E2F-1 and pRB changed 
with different E2F-1 mutants. Data presented in this 
study suggests that in vivo phosphorylation at amino 
acids 332-337, 375 and 403 is important for the E2F-1 
and pRB interaction. Contrary to previous report [12], 
the E2F-1/S375A and E2F-1/S403A mutants bound 
more pRB compared to E2F-1/wt as measured in 
immunoprecipitation assays (Fig. 4). This discrepancy 
may arise from the fact that the previous experiments 
were done in vitro using extracts from insect cells ex-
pressing E2F-1 and a pRB GST fusion protein. Indeed, 
it has been shown that site 403 is also phosphorylated 
and this phosphorylation increases the E2F-1 degra-
dation in another experiment [13]. Mutation of phos-
phorylation site S403 increased the stability of the 
E2F-1. Morever, it was shown that E2F-1 is stabilized 
by its interaction with pRB [33]. Therefore, it is rea-
sonable to think that increased affinity of mutant 403 
to pRB increases the stability of 403 mutant.  
  The cell cycle and transformation efficiency re-
sults for the E2F-1/Y411A mutant could be predicted 
and correlated well with known information. For 
example, it was shown earlier that its overexpression 
in the cell pushes the cell into S phase more efficiently 
compared to E2F-1/wt [14]. The same result was 
found in this study. Its binding affinity to pRB was 
also found to be in agreement with earlier in vitro 
studies. Transformation efficiency results were also 
well correlated with the result of cell cycle and 
E2F-1/Y411A pRB-binding experiments in this study. 
Therefore, free E2F-1, unbound to pRB, increased S 
phase entry and transformation of ψ-CRE cell. These 
results provided direct evidence for the biological 
significance of the E2F-1 and E2F-1/pRB interaction 
for proper cell cycle and tumor formation.  
Although, we hypothesized that E2F-1/Y411A 
and E2F-1/L132Q overexpressing cells will show 
similar phenotypes, since both cell lines have more 
free E2F-1, the E2F-1/L132Q mutant showed the op-
posite results in the soft agar and cell cycle experi-
ments. Although the E2F-1/L132Q mutants showed Int. J. Biol. Sci. 2010, 6 
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higher transformation efficiency compared to the 
pX17 in this study similar to previous study done in 
melanocytes [34], it did not show the expected result 
for the cell cycle. For example, overexpression of 
E2F-1/L132Q did not significantly push the cell into S 
phase more than control (Fig. 6). Therefore, it is in-
teresting to consider the possibility that free E2F-1 
provides the tumor cells with a growth advantage 
beyond simply shortening G1. This idea is also sup-
ported by the target gene expression results, which is 
described in the following paragraphs.  
Data also shows that although E2F-1 mutants 
332-7, 375 and 403 showed similar binding affinity to 
pRB, they showed different characteristics in trans-
formation efficiency, G0/G1 accumulation, and target 
gene experiments. Interestingly, the E2F-1/S332-7A 
mutant was more efficient in transforming cells than 
E2F-1/wt. Another interesting result was seen in the 
E2F-1/S403A mutant. Although the E2F-1/S403A 
mutant binds pRB as efficiently as the E2F-1/S332-7A 
mutant, it did not show an increase in transformation 
efficiency. Unexpectedly, the E2F-1/S403A mutant 
showed less accumulation in G0 than the E2F-1/wt. 
This finding was inconsistent with very low 
E2F-1/S403A transformation efficiency. Although 
there is no clue to explain these phenotypic changes 
with the known effects of mutants, it might be possi-
ble to explain these different characteristics to some 
degree with the results from the target gene experi-
ments. For example, c-myc oncogene expression was 
the least repressed in the E2F-1/S332-7A mutant ex-
pressing cells that produced one of the greatest 
numbers of transformed colonies. In the E2F-1/S403A 
expressing cells, RB gene expression was higher than 
that E2F-1/wt, which may be one of the reasons for 
having the lowest rate of transformation. It is worth 
mentioning that the E2F-1 target genes are not limited 
to those we checked in this study [35]. Therefore, it is 
possible that some other target genes might be af-
fected by the alteration of RB expression or by other 
target genes causing some unexpected phenotypic 
changes.  
The changes in target gene expression by the 
different mutants can be explained to some degree by 
the context of pRB binding to the particular E2F-1’s. 
For example, RB expression increased in E2F-1/wt 
overexpressing cell lines compared to that of control. 
In the same cell lines, all target gene expression, in-
cluding DHFR, b-myb, cdc-2, c-myc, cyclin D1 and TK 
were repressed compared to the control. Therefore, 
high amounts of E2F-1 and RB repressed expression 
of many of the target gene. This explanation will be 
more meaningful when the higher DNA binding af-
finity of E2F-1/pRB complex compared to free E2F-1 
and increased stability of E2F-1/pRB is considered 
[33, 36]. 
However, it is not possible to use the same rea-
soning to explain the effects of the E2F-1/S332-7A, 
E2F-1/S375A and E2F-1/S403A mutants. 
E2F-1/S332-7A, E2F-1/S375A and E2F-1/S403A 
overexpression increased RB expression more than 
that E2F-1/wt. Furthermore, it was shown that the 
E2F-1/S332-7A, E2F-1/S375A, E2F-1/S403A mutants 
bind pRB better than the E2F-1/wt binds to pRB in 
this study (Fig 4). Following the reasoning used 
above; there should be more E2F-1/pRB complexes on 
the target gene promoter and more repression on the 
target gene compared to the cells overexpressing 
E2F-1/wt. However, the opposite was found. There-
fore, in addition to pRB regulation on target gene 
promoter, some other factor must be effecting the 
target gene promoter. For example, Previous studies 
have shown that phosphorylation of E2F-1 changes its 
binding to DNA [37]. Similarly, it would be possible 
that mutation on E2F-1/S332-7A, E2F-1/S375A and 
E2F-1/S403A might affect E2F-1-DNA binding, and 
subsequently transcription. It is also possible that 
since the mutation of Serine sites 332-7, 375 and 403 is 
in the transactivation domain of E2F-1, which may 
change activation directly. Difference of the effects of 
mutant E2F-1, such as E2F-1/S403A increase RB ex-
pression more than E2F-1/S332-7A and 375 might be 
also related with the conformational changes of indi-
vidual mutants.  
We hypothesized that E2F-1/Y411A and 
E2F-1/L132Q overexpressing cells will have less pRB 
on the promoter of target genes. Excess E2F-1/L132Q 
binds to pRB proteins, and this complex will not be 
ab le t o  b in d t o  D NA. O n l y en do gen o u s, f ree E 2F - 1 
will bind to the promoter and thereby increase the 
activation or relieve the repression caused by the 
E2F-1/pRB complex. Similarly, it is hypothesized that 
excess E2F-1/Y411A binds the promoter more than 
the endogenous E2F-1/pRB complex and increases 
activation or relieves repression caused by the 
E2F-1/pRB complex. Indeed, this hypothesis appears 
true since most of the target genes were derepressed 
by both mutants. However, the effect of the 
E2F-1/Y411A and E2F-1/L132Q on RB was opposite 
of each other. RB expression increased more than 
two-fold in the cells overexpressing E2F-1/Y411A 
compared to that in E2F-1/wt, while a 20% decrease 
was observed in the cells overexpressing 
E2F-1/L132Q over control. Therefore, phenotypic 
differences between these mutant-overexpressing 
cells might be related with changes in the RB expres-
sion level.  Int. J. Biol. Sci. 2010, 6 
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The target gene expression results present an 
interesting and unexpected result. For example, 
overexpression of E2F-1/wt increased the transfor-
mation efficiency, however target genes expression 
known that related with cell proliferation or tumuro-
genesis including c-myc, b-myb, cyclin D1, cdc2 and 
TK were decreased. Surprisingly, pRB, a tumor sup-
pressor protein, expression level was increased. This 
result might suggest two things: first, there might be 
other target genes that have a more decisive role on 
the tumor formation other than what we studied. 
Second, exogenous E2F-1 induces transformation di-
rectly independent of its target genes. However, both 
suggestions are unlikely since the target genes we 
checked are well known oncogenes and regulated by 
E2F-1 as shown in this study (Fig. 7). Recently, we 
showed that E2F-1 acts in different ways, not only 
depending on the target gene but also depending on 
different stages of the cell cycle. For example, E2F-1 
acts as part of the repression complex with pRB in the 
expression of DHFR, b-myb, TK and cdc2 in asyn-
chronously growing cells; on the other hand, E2F-1 
acts as an activator in the expression of the same 
genes in cells that are re-entering the cycle [24]. 
Therefore, cell cycle dependent activity of the E2F-1 
might be the main determinant of growth regulation 
of the target genes followed by tumor formation.  
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Figures 
 
Figure S1. Densitometry analysis of the immunoblot of the wilt type and mutant E2F-1s. Immunoblot of wilt 
type and mutant E2F –1s were analyzed by computer assisted densitometry analyzes. X axis shows the molecular weight of 
the protein, Y-axis shows optic density of the individual bands. 
 
Figure S2. Equivalent amount cell free extracts from of the cell lines were analyzed by immunoblotting using anti-pRb 
specific polyclonal antibody after separation on 10% SDS-PAGE. The position of the pRb and actin bands is indicated on the 
right. 
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